Presentation is loading. Please wait.

Presentation is loading. Please wait.

I.V. APD421 (amisulpride) prevents postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled, multicentre trial  P. Kranke, L.

Similar presentations


Presentation on theme: "I.V. APD421 (amisulpride) prevents postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled, multicentre trial  P. Kranke, L."— Presentation transcript:

1 I.V. APD421 (amisulpride) prevents postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled, multicentre trial  P. Kranke, L. Eberhart, J. Motsch, D. Chassard, J. Wallenborn, P. Diemunsch, N. Liu, D. Keh, H. Bouaziz, M. Bergis, G. Fox, T.J. Gan  British Journal of Anaesthesia  Volume 111, Issue 6, Pages (December 2013) DOI: /bja/aet251 Copyright © 2013 The Author(s) Terms and Conditions

2 Fig 1 Flowchart. TIVA-propofol, total i.v. anaesthesia with propofol; Preop N&V, preoperative nausea and vomiting. British Journal of Anaesthesia  , DOI: ( /bja/aet251) Copyright © 2013 The Author(s) Terms and Conditions

3 Fig 2 Time to first incidence of PONV.
British Journal of Anaesthesia  , DOI: ( /bja/aet251) Copyright © 2013 The Author(s) Terms and Conditions


Download ppt "I.V. APD421 (amisulpride) prevents postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled, multicentre trial  P. Kranke, L."

Similar presentations


Ads by Google